Jackelyne Oliveira Costa Tenório
Jackelyne Oliveira Costa Tenório has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Josemir de Almeida Lima
Cesmac
3 shared publications - Karina Brandão Menezes Lima
Centro Universitário de Maceió UNIMA
3 shared publications - Geórgia Maria Ricardo Félix dos Santos
Universidade Estadual de Ciências da Saúde de Alagoas
2 shared publications - Leandro Maia Leão
Faculdade Iguaçu
2 shared publications - Aldrya Ketly Pedrosa
Cesmac
1 shared publication - Aline de Araújo Marques Mousinho
Centro Universitário de Maceió, Brasil
1 shared publication
Latest Publications
- Open Access
- 1 August 2025
- Published by Research, Society and Development in Research, Society and Development
- Vol. 14 (8)
Imunoterapia por Receptores de Antígenos Quiméricos (CARs) para células Assassinas Naturais (NK), abordagens terapêuticas e perspectivas futuras na área oncológica: uma revisão sistemática de Síntese Sem Metanálise (SWIM)
CAR-T cell immunotherapy, despite its success in hematological malignancies, is limited by significant toxicities and high production costs. CAR-NK immunotherapy emerges as an alternative, with the potential for safer and more accessible "off-the-shelf" allogeneic products. The objective was to critically analyze the evidence on the production, efficacy, challenges, and future perspectives of CAR-NK immunotherapy. A systematic review was conducted using the SWIM (Synthesis Without Meta-analysis) protocol, with the analysis of 83 documents (after applying inclusion and exclusion criteria) analyzed via Bardin's Content Analysis. High efficacy was demonstrated in hematological malignancies, but limited success in solid tumors due to low persistence and suppression by the Tumor Microenvironment (TME). The strategic transition to Induced Pluripotent Stem Cells (iPSCs) is the foundation for producing universal CAR-NK immunotherapies. Overcoming barriers in solid tumors depends on the engineering of multifunctional "armored" CAR-NK cells. This includes the development of "NK-centric" constructs (such as the NKG2D domain), the co-expression of supportive Interleukins (IL-15/IL-21) to increase persistence, and gene editing (via CRISPR-Cas9) to resist TME suppression and metabolic stress (e.g., DRP1 ablation). The integration of these advanced strategies into iPSC platforms is fundamental to consolidating CAR-NK therapy as an accessible and effective pillar in the treatment of cancer and autoimmune diseases. For this, conducting more robust studies is of utmost importance in order to improve the scientific evidence regarding this therapy.
- 1 August 2025
- Published by Research, Society and Development in Research, Society and Development
- Vol. 14 (8)
Open AccessImunoterapia por Receptores de Antígenos Quiméricos (CARs) para células Assassinas Naturais (NK), abordagens terapêuticas e perspectivas futuras na área oncológica: uma revisão sistemática de Síntese Sem Metanálise (SWIM)
CAR-T cell immunotherapy, despite its success in hematological malignancies, is limited by significant toxicities and high production costs. CAR-NK immunotherapy emerges as an alternative, with the potential for safer and more accessible "off-the-shelf" allogeneic products. The objective was to critically analyze the evidence on the production, efficacy, challenges, and future perspectives of CAR-NK immunotherapy. A systematic review was conducted using the SWIM (Synthesis Without Meta-analysis) protocol, with the analysis of 83 documents (after applying inclusion and exclusion criteria) analyzed via Bardin's Content Analysis. High efficacy was demonstrated in hematological malignancies, but limited success in solid tumors due to low persistence and suppression by the Tumor Microenvironment (TME). The strategic transition to Induced Pluripotent Stem Cells (iPSCs) is the foundation for producing universal CAR-NK immunotherapies. Overcoming barriers in solid tumors depends on the engineering of multifunctional "armored" CAR-NK cells. This includes the development of "NK-centric" constructs (such as the NKG2D domain), the co-expression of supportive Interleukins (IL-15/IL-21) to increase persistence, and gene editing (via CRISPR-Cas9) to resist TME suppression and metabolic stress (e.g., DRP1 ablation). The integration of these advanced strategies into iPSC platforms is fundamental to consolidating CAR-NK therapy as an accessible and effective pillar in the treatment of cancer and autoimmune diseases. For this, conducting more robust studies is of utmost importance in order to improve the scientific evidence regarding this therapy.
- 14 May 2025
- Published by Revista ft Ltda in Revista ft
- Vol. 29 (146) , 28-29
IMUNOTERAPIA POR RECEPTORES DE ANTÍGENOS QUIMÉRICOS NO TRATAMENTO ONCOLÓGICO: UMA REVISÃO INTEGRATIVA
INTRODUCTION: Adoptive Cellular Immunotherapy (ICA) through Chimeric Antigen Receptors (CARs) has shown great efficacy in the oncological area, especially in malignancies of the hematopoietic system. However, there are still some limitations to be resolved, such as a better understanding of the adverse effects of therapy, the efficacy of this treatment for solid tumors and efficacy for heterogeneous cancers. OBJECTIVE: To highlight the current contributions and future prospects of chimeric antigen receptor immunotherapy in the oncology field. METHODOLOGY: This is an integrative literature review with a qualitative analysis. The databases used to search for the articles were: Nature, The Lancet and PubMed; a total of 6273 articles were found using the descriptors: ”CAR-T Cell Therapy OR CAR NK Cell Therapy AND Remission Induction”; ”Adoptive Cell Therapy OR Immunotherapy AND CAR-T Cell AND Future Directions” with some criteria from the PRISMA2020 flowchart being used, and Textual Discourse Analysis (TDA) being used to form the units of meaning in the data analysis. RESULTS: After applying the inclusion and exclusion criteria, 14 articles were selected over a 5-year period. DISCUSSION: It was found that CAR-T cells promote partial and/or total remissions of hematological malignancies and are more effective in homogeneous cancers, while CAR-NK cells, in addition to these therapeutic properties, are better at infiltrating the microenvironment of solid tumors. CONCLUSION: CAR immunotherapy shows great potential for achieving remission in numerous types of cancer, as it has already demonstrated in its applications around the world. However, some limitations still need to be overcome, such as: a better general understanding of the adverse effects (neurotoxic syndromes) that it can present, and the development of multisignaling CARs, in order to increase the effectiveness of treatment in heterogeneous cancers. Keywords: Adoptive Immunotherapy; Chimeric Antigen Receptors; Clinical Oncology
- 14 May 2025
- Published by Revista ft Ltda in Revista ft
- Vol. 29 (146) , 28-29
IMUNOTERAPIA POR RECEPTORES DE ANTÍGENOS QUIMÉRICOS NO TRATAMENTO ONCOLÓGICO: UMA REVISÃO INTEGRATIVA
INTRODUCTION: Adoptive Cellular Immunotherapy (ICA) through Chimeric Antigen Receptors (CARs) has shown great efficacy in the oncological area, especially in malignancies of the hematopoietic system. However, there are still some limitations to be resolved, such as a better understanding of the adverse effects of therapy, the efficacy of this treatment for solid tumors and efficacy for heterogeneous cancers. OBJECTIVE: To highlight the current contributions and future prospects of chimeric antigen receptor immunotherapy in the oncology field. METHODOLOGY: This is an integrative literature review with a qualitative analysis. The databases used to search for the articles were: Nature, The Lancet and PubMed; a total of 6273 articles were found using the descriptors: ”CAR-T Cell Therapy OR CAR NK Cell Therapy AND Remission Induction”; ”Adoptive Cell Therapy OR Immunotherapy AND CAR-T Cell AND Future Directions” with some criteria from the PRISMA2020 flowchart being used, and Textual Discourse Analysis (TDA) being used to form the units of meaning in the data analysis. RESULTS: After applying the inclusion and exclusion criteria, 14 articles were selected over a 5-year period. DISCUSSION: It was found that CAR-T cells promote partial and/or total remissions of hematological malignancies and are more effective in homogeneous cancers, while CAR-NK cells, in addition to these therapeutic properties, are better at infiltrating the microenvironment of solid tumors. CONCLUSION: CAR immunotherapy shows great potential for achieving remission in numerous types of cancer, as it has already demonstrated in its applications around the world. However, some limitations still need to be overcome, such as: a better general understanding of the adverse effects (neurotoxic syndromes) that it can present, and the development of multisignaling CARs, in order to increase the effectiveness of treatment in heterogeneous cancers. Keywords: Adoptive Immunotherapy; Chimeric Antigen Receptors; Clinical Oncology
- Open Access
- 29 November 2023
- Published by Atlântica Editora in Enfermagem Brasil
- Vol. 22 (5) , 547-563
Religiosidade e espiritualidade na percepção de estudantes de graduação em Enfermagem
Introdução: A espiritualidade e a religiosidade são distintas dimensões do ser humano que podem impactar na assistência de enfermagem, proporcionando bem-estar físico, melhora no relacionamento interpessoal e qualidade de vida. Objetivo: Analisar a percepção dos estudantes de Enfermagem de um Centro Universitário privado de Alagoas- Brasil acerca da Religiosidade/ Espiritualidade no contexto do curso de graduação e da prática clínica. Materiais e métodos: estudo de campo, descritivo, exploratório, transversal de abordagem quantitativa. O instrumento foi um questionário validado, com questões semiestruturadas, auto aplicadas em 220 estudantes do curso de enfermagem. A coleta foi realizada em dezembro de 2018. Os dados coletados foram armazenados, tabulados e analisados através do programa Bioestat versão 5.4. Resultados: o sexo feminino foi predominante (80%); residentes em Maceió (57,7%) e predominantemente católicos (63,00%). Sobre a percepção acerca da religiosidade/espiritualidade: maioria afirma que o tema é abordado deficientemente e pouco preparo para incluí-lo na prática clínica. Conclusão: O curso investigado não estimula o acesso à temática, a mudança de abordagem possibilita a inclusão na prática clínica.
- 29 November 2023
- Published by Atlântica Editora in Enfermagem Brasil
- Vol. 22 (5) , 547-563
Open AccessReligiosidade e espiritualidade na percepção de estudantes de graduação em Enfermagem
Introdução: A espiritualidade e a religiosidade são distintas dimensões do ser humano que podem impactar na assistência de enfermagem, proporcionando bem-estar físico, melhora no relacionamento interpessoal e qualidade de vida. Objetivo: Analisar a percepção dos estudantes de Enfermagem de um Centro Universitário privado de Alagoas- Brasil acerca da Religiosidade/ Espiritualidade no contexto do curso de graduação e da prática clínica. Materiais e métodos: estudo de campo, descritivo, exploratório, transversal de abordagem quantitativa. O instrumento foi um questionário validado, com questões semiestruturadas, auto aplicadas em 220 estudantes do curso de enfermagem. A coleta foi realizada em dezembro de 2018. Os dados coletados foram armazenados, tabulados e analisados através do programa Bioestat versão 5.4. Resultados: o sexo feminino foi predominante (80%); residentes em Maceió (57,7%) e predominantemente católicos (63,00%). Sobre a percepção acerca da religiosidade/espiritualidade: maioria afirma que o tema é abordado deficientemente e pouco preparo para incluí-lo na prática clínica. Conclusão: O curso investigado não estimula o acesso à temática, a mudança de abordagem possibilita a inclusão na prática clínica.